Effect of chronic treatment with an estrogen-progestogen combination on beta adrenergic-induced thirst.
D000818:Animals; D003681:Dehydration / Q000503:physiopathology; D004338:Drug Combinations; D004837:Epinephrine / Q000494:pharmacology; D004997:Ethinyl Estradiol / Q000494:pharmacology*; D005260:Female; D006982:Hypertonic Solutions; D007545:Isoproterenol / Q000494:pharmacology; D009641:Norethynodrel / Q000494:pharmacology*; D010656:Phenylephrine / Q000494:pharmacology; D051381:Rats; D011941:Receptors, Adrenergic / Q000502:physiology*; D011943:Receptors, Adrenergic, beta / Q000502:physiology*; D012701:Serotonin / Q000494:pharmacology; D012965:Sodium Chloride / Q000494:pharmacology; D013894:Thirst / Q000187:drug effects* / Q000502:physiology
D004338:Drug Combinations; D006982:Hypertonic Solutions; D011941:Receptors, Adrenergic; D011943:Receptors, Adrenergic, beta; D010656:Phenylephrine; D012701:Serotonin; D004997:Ethinyl Estradiol; D012965:Sodium Chloride; D009641:Norethynodrel; D007545:Isoproterenol; D004837:Epinephrine